Harold Brey & Sons Inc.
Letter data
- Company
- Harold Brey & Sons Inc.
- Recipient
- Mr. Daniel Brey & Ms. Nancy Brey | Co-Owners | Harold Brey & Sons Inc. | 607 Swiss Hill Rd. | Jeffersonville | , | NY | 12748 | United States
- Issue date
- 2020-04-02
- Posted date
- Not available
- FDA office
- Office of Human and Animal Food Operations East Division 1
- Subject
- Not available
- Product
- Food & Beverages
- CMS ID
- 585292
- Reference number
- Not available
- FEI
- Not available
- Inspection dates
- Not available
Normalized citations
21 CFR: None found
21 U.S.C.: None found
Related FDA links
No related FDA letter link is present in the source index.
Full source text
CLOSEOUT LETTER
Harold Brey & Sons Inc.
MARCS-CMS 585292 —
April 02, 2020
More Warning Letters
Warning Letters
About Warning and Close-Out Letters
Delivery Method:
VIA UNITED PARCEL SERVICE
Product:
Food & Beverages
Recipient:
Recipient Name
Mr. Daniel Brey & Ms. Nancy Brey
Recipient Title
Co-Owners
Harold Brey & Sons Inc.
607 Swiss Hill Rd.
Jeffersonville
,
NY
12748
United States
Issuing Office:
Office of Human and Animal Food Operations East Division 1
United States
Dear Mr. & Ms. Brey:
The Food and Drug Administration has completed an evaluation of your firm's corrective actions in response to our Warning Letter 585292, issued on September 24, 2019. Based on our evaluation, it appears that you have addressed the violations contained in this Warning Letter. Future FDA inspections and regulatory activities will further assess the adequacy and sustainability of these corrections.
This letter does not relieve you or your firm from the responsibility of taking all necessary steps to assure sustained compliance with the Federal Food, Drug, and Cosmetic Act and its implementing regulations or with other relevant legal authority. The Agency expects you and your firm to maintain compliance and will continue to monitor your state of compliance. This letter will not preclude any future regulatory action should violations be observed during a subsequent inspection or through other means.
Sincerely,
/S/
Scott M. Loughan
Acting Director, Compliance Branch
Office of Human and Animal Food Operations East Division 1
Content current as of:
04/10/2020
Regulated Product(s)
Food & Beverages